US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist
  • 13.710
  • +0.150+1.11%
Close Nov 26 16:00 ET
22.74MMarket Cap-2224P/E (TTM)

Cadrenal Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
115.30%2.46M
140.37%2.47M
-58.20%1.76M
7.63M
1.26M
17.46%1.14M
112.75%1.03M
2,363.18%4.2M
972.79K
482.35K
Selling and administrative expenses
86.50%1.67M
54.52%1.21M
16.72%1.13M
--3.55M
--902.11K
-1.95%898.05K
180.11%784.62K
531.94%964.73K
--915.9K
--280.11K
-General and administrative expense
86.50%1.67M
54.52%1.21M
16.72%1.13M
--3.55M
--902.11K
-1.95%898.05K
180.11%784.62K
531.94%964.73K
--915.9K
--280.11K
Research and development costs
221.64%784.65K
420.30%1.25M
-80.56%629.03K
--4.08M
--361.13K
332.62%243.95K
19.15%240.96K
18,014.88%3.24M
--56.39K
--202.24K
Depreciation amortization depletion
-31.83%407
-21.27%470
214.21%597
--1.98K
--597
17.98%597
--597
--190
--506
--0
-Depreciation and amortization
-31.83%407
-21.27%470
214.21%597
--1.98K
--597
17.98%597
--597
--190
--506
--0
Operating profit
-115.30%-2.46M
-140.37%-2.47M
58.20%-1.76M
-7.63M
-1.26M
-17.46%-1.14M
-112.75%-1.03M
-2,363.18%-4.2M
-972.79K
-482.35K
Net non-operating interest income expense
-50.89%52.13K
217.73%73.64K
639.89%92.33K
231.99K
119.77K
431.59%106.15K
256.91%23.18K
-272.65%-17.1K
-32.01K
-14.77K
Non-operating interest income
-50.89%52.13K
217.73%73.64K
--92.33K
--249.09K
--119.77K
3,538,066.67%106.15K
--23.18K
--0
--3
--0
Non-operating interest expense
--0
--0
--0
--17.1K
--0
--0
--0
272.65%17.1K
--32.01K
--14.77K
Other net income (expense)
-956.23K
0
-62,073.86%-956.23K
-21.31K
-5.02K
Gain on sale of security
----
----
----
---216.1K
--0
----
----
-13,950.39%-216.1K
---21.31K
---5.02K
Special income (charges)
--0
--0
--0
---740.14K
--0
--0
--0
---740.14K
--0
--0
-Less:Other special charges
----
----
----
--740.14K
--0
----
----
--740.14K
----
----
Income before tax
-132.31%-2.41M
-138.58%-2.39M
67.85%-1.66M
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
Income tax
Net income
-132.31%-2.41M
-138.58%-2.39M
67.85%-1.66M
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
Net income continuous Operations
-132.31%-2.41M
-138.58%-2.39M
67.85%-1.66M
---8.36M
---1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
---1.03M
---502.14K
Minority interest income
Net income attributable to the parent company
-132.31%-2.41M
-138.58%-2.39M
67.85%-1.66M
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-132.31%-2.41M
-138.58%-2.39M
67.85%-1.66M
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
Basic earnings per share
-115.84%-2.18
-66.67%-2.25
79.17%-1.5
-9.3
-0.74
23.65%-1.01
-108.53%-1.35
-3,061.43%-7.2
-1.3229
-0.6474
Diluted earnings per share
-115.84%-2.18
-66.67%-2.25
79.17%-1.5
-9.3
-0.74
23.65%-1.01
-108.53%-1.35
-3,061.43%-7.2
-1.3229
-0.6474
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 115.30%2.46M140.37%2.47M-58.20%1.76M7.63M1.26M17.46%1.14M112.75%1.03M2,363.18%4.2M972.79K482.35K
Selling and administrative expenses 86.50%1.67M54.52%1.21M16.72%1.13M--3.55M--902.11K-1.95%898.05K180.11%784.62K531.94%964.73K--915.9K--280.11K
-General and administrative expense 86.50%1.67M54.52%1.21M16.72%1.13M--3.55M--902.11K-1.95%898.05K180.11%784.62K531.94%964.73K--915.9K--280.11K
Research and development costs 221.64%784.65K420.30%1.25M-80.56%629.03K--4.08M--361.13K332.62%243.95K19.15%240.96K18,014.88%3.24M--56.39K--202.24K
Depreciation amortization depletion -31.83%407-21.27%470214.21%597--1.98K--59717.98%597--597--190--506--0
-Depreciation and amortization -31.83%407-21.27%470214.21%597--1.98K--59717.98%597--597--190--506--0
Operating profit -115.30%-2.46M-140.37%-2.47M58.20%-1.76M-7.63M-1.26M-17.46%-1.14M-112.75%-1.03M-2,363.18%-4.2M-972.79K-482.35K
Net non-operating interest income expense -50.89%52.13K217.73%73.64K639.89%92.33K231.99K119.77K431.59%106.15K256.91%23.18K-272.65%-17.1K-32.01K-14.77K
Non-operating interest income -50.89%52.13K217.73%73.64K--92.33K--249.09K--119.77K3,538,066.67%106.15K--23.18K--0--3--0
Non-operating interest expense --0--0--0--17.1K--0--0--0272.65%17.1K--32.01K--14.77K
Other net income (expense) -956.23K0-62,073.86%-956.23K-21.31K-5.02K
Gain on sale of security ---------------216.1K--0---------13,950.39%-216.1K---21.31K---5.02K
Special income (charges) --0--0--0---740.14K--0--0--0---740.14K--0--0
-Less:Other special charges --------------740.14K--0----------740.14K--------
Income before tax -132.31%-2.41M-138.58%-2.39M67.85%-1.66M-8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K
Income tax
Net income -132.31%-2.41M-138.58%-2.39M67.85%-1.66M-8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K
Net income continuous Operations -132.31%-2.41M-138.58%-2.39M67.85%-1.66M---8.36M---1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M---1.03M---502.14K
Minority interest income
Net income attributable to the parent company -132.31%-2.41M-138.58%-2.39M67.85%-1.66M-8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -132.31%-2.41M-138.58%-2.39M67.85%-1.66M-8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K
Basic earnings per share -115.84%-2.18-66.67%-2.2579.17%-1.5-9.3-0.7423.65%-1.01-108.53%-1.35-3,061.43%-7.2-1.3229-0.6474
Diluted earnings per share -115.84%-2.18-66.67%-2.2579.17%-1.5-9.3-0.7423.65%-1.01-108.53%-1.35-3,061.43%-7.2-1.3229-0.6474
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data